|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2011-5-24
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus ritonavir (ATV/r), on bone mineral density (BMD) have not been analyzed.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenine,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoxazines,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/Ritonavir,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir, lamivudine drug...,
http://linkedlifedata.com/resource/pubmed/chemical/atazanavir,
http://linkedlifedata.com/resource/pubmed/chemical/efavirenz,
http://linkedlifedata.com/resource/pubmed/chemical/emtricitabine,
http://linkedlifedata.com/resource/pubmed/chemical/tenofovir disoproxil
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1537-6613
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
203
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1791-801
|
|
pubmed:dateRevised |
2011-10-11
|
|
pubmed:meshHeading |
pubmed-meshheading:21606537-Absorptiometry, Photon,
pubmed-meshheading:21606537-Adenine,
pubmed-meshheading:21606537-Adult,
pubmed-meshheading:21606537-Anti-HIV Agents,
pubmed-meshheading:21606537-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:21606537-Benzoxazines,
pubmed-meshheading:21606537-Bone Density,
pubmed-meshheading:21606537-CD4 Lymphocyte Count,
pubmed-meshheading:21606537-Deoxycytidine,
pubmed-meshheading:21606537-Dideoxynucleosides,
pubmed-meshheading:21606537-Drug Combinations,
pubmed-meshheading:21606537-Drug Therapy, Combination,
pubmed-meshheading:21606537-Female,
pubmed-meshheading:21606537-Fractures, Bone,
pubmed-meshheading:21606537-HIV Infections,
pubmed-meshheading:21606537-Humans,
pubmed-meshheading:21606537-Intention to Treat Analysis,
pubmed-meshheading:21606537-Lamivudine,
pubmed-meshheading:21606537-Male,
pubmed-meshheading:21606537-Middle Aged,
pubmed-meshheading:21606537-Oligopeptides,
pubmed-meshheading:21606537-Osteoporosis,
pubmed-meshheading:21606537-Phosphonic Acids,
pubmed-meshheading:21606537-Pyridines,
pubmed-meshheading:21606537-Risk Factors,
pubmed-meshheading:21606537-Ritonavir,
pubmed-meshheading:21606537-Viral Load
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.
|
|
pubmed:affiliation |
Departments of Pediatrics and Medicine, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA. grace.mccomsey@case.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
